Previous 10 | Next 10 |
home / stock / lbltf / lbltf news
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) is pleased to announce that it has entered into a definitive agreement (the "Agreement") with Alumina Partners (Ontario) Ltd. (" Alumina ") for a commitment of up to $6,...
Point Roberts, WA and Delta, BC - March 20, 2020 (Investorideas.com Newswire) Investorideas.com , a global news source and leading investor resource announces its weekly roundup of stocks added to its global stock directories, including biotech, mining, tech, home-builder and cleantech. This ...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) announces it has begun enrolling patients in its Phase 1 clinical trial to address safety and efficacy of its novel stem cell technology, AmnioBoost, for the treatment of ...
Lattice Biologics Ltd. ( TSX-V: LBL ) ( OTCQB: LBLTF ) (“ Lattice Biologics ” or the “ Company ”) today announced that it plans to evaluate its amniotic fluid concentrate, AmnioBoost, in patients with acute respiratory distress syndrome (ARDS) caused by coronavir...
Lattice Biologics Ltd. ( TSX-V: LBL ) ( OTCQB: LBLTF ) (“ Lattice Biologics ” or the “ Company ”) announces that, subject to TSXV approval, the Company plans to convert US $726,200 (Can$1,000,000) of debt (the “ Debt “) into equity of Lattice Biolog...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announces financial results for Q1 2020. Highlights of the Three Months Ended December 31, 2019 Sales and Product Offerings - Completion of the re...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announces financial results for the fiscal year end 2019 and preliminary revenues for Q1 2020. Sales and Product Offerings S uccessfully relocated pro...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announces financial results for Q3 2019. Sales and Product Offerings - Completion of the relocated processing facility to Belgrade, Montana and expandi...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announces financial results for Q2 2019. Sales and Product Offerings Completion of the relocated processing facility to Belgrade, Montana and expanding ...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announces financial results for Q1 2019, and preliminary revenues for Q2 2019. Sales and Product Offerings Completion of the relocated processing facili...
News, Short Squeeze, Breakout and More Instantly...
Lattice Biologics Ltd Company Name:
LBLTF Stock Symbol:
OTCMKTS Market:
Late in the trading day on Friday, July, 9, Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) issued an update on the company which has been unable to trade its stock for over a month. The company had originally made biologic products for use in the field of bone regeneration i...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announces financial results for Q2 2021. Highlights of Six Months Ended March 31, 2021 Sales and Product Offerings ...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“Lattice” or the “Company”), an emerging leader in psilocybin research and cannabis company, today announced the formation of its Strategic Advisory Board, a group of respected business leaders that wi...